Veterinary Reference Laboratory Market Size & Growth Forecast to 2030

Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030

USD 6.45 BN

MARKET SIZE, 2030

CAGR 6.3%

(2025-2030)

450

REPORT PAGES

500

MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period. Veterinary reference laboratories offer a range of routine and specialty testing services to veterinarians, pet owners, livestock producers, and research institutions, enabling the early diagnosis, evaluation, and monitoring of diseases and disorders in both livestock and companion animals.

KEY TAKEAWAYS

BY SERVICE

The service segment is sub segmented into Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Histopathology & Cytology, Microbiology, and Other Diagnostic Services. The clinical chemistry segment accounted for the largest market share in 2024. Its dominance is driven by widespread use in routine health screening, organ function evaluation, metabolic profiling, and chronic disease monitoring, making it the most frequently requested diagnostic category across veterinary practices.
BY APPLICATION

This is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Productivity Testing, Pregnancy Testing, Toxicology Testing, and Other Applications. The clinical pathology segment led the market in 2024. This leadership stems from its broad test portfolio, covering hematology, urinalysis, cytology, and biochemical evaluations essential for early disease detection and comprehensive patient assessment.
BY ANIMAL TYPE

The market is segmented into companion animals and livestock animals. In 2024, the companion animal segment held the largest market share. Rising pet ownership, increased spending on pet health, and growing demand for preventive diagnostic testing have made companion animals the primary contributors to reference lab test volumes.
BY END USER

The market is segmented into veterinary clinics & hospitals, research institutes & universities, point-of-care/in-house labs, and other end users. Veterinary clinics and hospitals accounted for the dominant market share in 2024. Their high caseloads, frequent use of diagnostic panels, and dependency on external laboratories for advanced and specialized testing drive this segment’s growth.
BY REGION

In 2024, North America accounted for the largest share of the veterinary reference laboratory market, driven by robust veterinary healthcare infrastructure, high pet healthcare expenditure, advanced diagnostic capabilities, and the presence of leading laboratory service providers. Asia Pacific is expected to grow the fastest, supported by rising livestock productivity needs, expanding companion animal population, and increasing awareness of disease diagnostics.
COMPETITIVE LANDSCAPE

The major market players have adopted both organic and inorganic strategies, including partnerships and collaborations. For instance, IDEXX launched the IDEXX Cancer Dx, a diagnostic panel for the early detection of lymphoma in dogs. It is a blood test that can be added to panels for sick pets and integrated into annual wellness screenings.

The Veterinary Reference Laboratory Market is expected to witness substantial growth in the coming years, driven by the rising burden of zoonotic and companion animal diseases, increasing demand for advanced diagnostic capabilities, and the growing need for rapid, accurate testing to support evidence-based veterinary care. Veterinary reference labs are increasingly being utilized for their ability to deliver high-precision results, support complex diagnostic workflows, and enhance clinical decision-making across small, mixed, and large animal practices. The shift toward molecular diagnostics, automation, and high-throughput testing platforms, along with the integration of AI-enabled analytics, further enhances the role of VRLs in improving diagnostic accuracy, reducing turnaround times, and enhancing overall patient outcomes. With expanding pet ownership, intensifying livestock health monitoring, and greater emphasis on preventive diagnostics, veterinary reference laboratories are becoming a critical component of modern veterinary healthcare delivery.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The evolving landscape of the veterinary reference laboratory market highlights key trends and disruptions that are reshaping revenue streams and altering end-user dynamics. As the industry shifts from conventional testing methods to more advanced, technology-driven diagnostic solutions, new high-growth opportunities are emerging, particularly in molecular diagnostics, automation, and AI-enabled interpretation. The increasing adoption of high-throughput platforms, integrated diagnostic ecosystems, and precision testing tools is transforming how laboratories operate and how veterinarians utilize diagnostic insights. This transition toward faster, more accurate, and more data-centric testing is redefining the competitive environment and unlocking significant potential across both companion animal and livestock segments.

Veterinary Reference Laboratory Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Growing routine wellness & oncology screening in companion animals
Increasing prevalence and awareness about zoonotic & emerging diseases

RESTRAINTS

Impact
Level

Competition from in-clinic & point-of-care testing
High capital investment and fixed cost burden in veterinary reference laboratories

OPPORTUNITIES

Impact
Level

Growth potential in emerging economies
Investments in advanced technologies in veterinary reference laboratories

CHALLENGES

Impact
Level

Competitive pressure and margin pressure in veterinary reference laboratories
Data privacy, biosecurity, and sample ownership in veterinary reference laboratories

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing routine wellness & oncology screening in companion animals

The veterinary reference laboratory market is experiencing strong momentum driven by the rising need for routine wellness diagnostics and oncology screening in companion animals, alongside increasing awareness of zoonotic and emerging infectious diseases. Pet owners are prioritizing preventive care and early detection, leading to higher testing volumes for hematology, biochemistry, oncology markers, and advanced pathology. Simultaneously, concerns over zoonotic pathogens and the need for One Health preparedness are driving a greater reliance on molecular diagnostics, PCR-based surveillance, and rapid pathogen identification. Together, these trends are accelerating the adoption of specialized reference laboratory services across both companion and livestock segments, strengthening demand for high-accuracy, technology-driven diagnostic solutions.

Restraint: Competition from in-clinic & point-of-care testing

The veterinary reference laboratory market faces significant restraints due to the growing adoption of in-clinic and point-of-care (POC) analyzers, as well as the substantial capital and fixed costs associated with operating large-scale reference laboratories. As POC devices become more accurate, affordable, and convenient, many practices prefer immediate in-house testing for routine diagnostics, reducing external lab volumes. Meanwhile, reference labs must sustain high operational expenses, including advanced analyzers, skilled personnel, facility accreditation, and continuous quality control, while competing in an increasingly price-sensitive environment. This combination of declining routine outsourcing and elevated cost structures poses a major barrier to profitability and market expansion.

Opportunity: Growth potential in emerging economies

Significant growth opportunities for veterinary reference laboratories stem from expanding into emerging economies and accelerating the adoption of advanced diagnostic technologies. Rising companion animal ownership, increasing livestock health programs, and improving veterinary infrastructure in developing regions are generating strong demand for outsourced diagnostic services. Simultaneously, innovations such as next-generation sequencing, multiplex PCR, digital cytology, robotics, and AI-driven diagnostic interpretation enable laboratories to enhance accuracy, increase throughput, and enter higher-value specialty testing segments. The combined potential of geographic expansion and technological modernization positions reference labs to capture significant new revenue streams and strengthen market leadership.

Challenge: Data privacy, biosecurity, and sample ownership in veterinary reference laboratories

Veterinary reference laboratories face escalating challenges from competitive pricing pressures, heightened data privacy concerns, and stringent biosecurity requirements. The commoditization of routine tests and growing adoption of in-clinic analyzers are intensifying margin compression, requiring labs to differentiate through specialized assays and operational efficiency. At the same time, increasing digital connectivity and molecular testing raise the need for robust cybersecurity systems, secure data sharing protocols, and clear policies around sample and genomic data ownership. Additionally, handling and transporting infectious or high-risk specimens demand strict biosecurity protocols and regulatory compliance. Together, these pressures create a complex operating environment that requires continuous investment, operational precision, and regulatory vigilance.

Veterinary Reference Laboratory Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Comprehensive reference lab testing, digital cytology, integrated results via VetConnect PLUS	Faster diagnoses, improved clinical accuracy, seamless workflow integration, specialist pathologist access
	Full-service reference lab with high-throughput facilities, integrated with in-clinic diagnostics	Faster turnaround, consistent quality, unified diagnostics ecosystem, better clinical decision-making
	AI-assisted diagnostic interpretation, expanded reference lab network (SYNLAB Vet acquisition)	Quicker image/test review, scalable lab capacity, improved diagnostic reliability
	Broad diagnostic panels across species, specialist microbiology/genetics/endocrinology services	Access to advanced tests, expert consultations, enhanced case management for complex conditions
	UK-wide diagnostic services supporting clinics with biochemistry, hematology, pathology, PCR	Reliable logistics, faster sample handling, comprehensive test menu for companion animals

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The veterinary reference laboratory market ecosystem comprises veterinary reference laboratories, technology partners, regulatory bodies, and end users. Reference laboratories form the core of this ecosystem and rely on technology partners for advanced diagnostic platforms, laboratory information management systems (LIMS), AI-enabled image analysis, logistics solutions, and quality-control systems. These technology partners also support integration with in-clinic analyzers, digital cytology platforms, teleconsultation systems, and electronic medical records, ensuring seamless data exchange. Veterinary practices, including independent clinics, corporate hospital chains, point-of-care /in-house labs, and research institutes & university veterinary hospitals, are the primary users of reference lab services. They rely on these laboratories for accurate, high-complexity testing, timely reporting, and specialized interpretation to enhance diagnostic confidence and inform clinical decision-making. Regulatory bodies, such as the USDA (US), EMA, and national veterinary authorities in Europe, as well as regional animal health agencies, play a critical role in defining standards for diagnostic quality, biosafety, sample handling, and laboratory accreditation. These regulations have a direct impact on laboratory workflows, technology adoption, and service expansion. End users shape the ecosystem by driving demand for faster turnaround, reliable diagnostics, and accessible reporting that improves transparency and patient outcomes.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary reference laboratory Market, By Service

Clinical chemistry held the largest share of the veterinary reference laboratory market, driven by its broad applicability across routine diagnostics, disease monitoring, and overall health assessment in both companion and livestock animals. This segment benefits from the high volume of biochemical tests requested by veterinarians to evaluate organ function, electrolyte balance, metabolic status, and the progression of chronic diseases. Clinical chemistry services are widely adopted due to their reliability, fast turnaround times, and essential role in guiding clinical decision-making. The increasing prevalence of lifestyle-related disorders in companion animals, the rising geriatric pet population, and expanding health screening programs further reinforce the dominance of this segment. As veterinary practices continue to emphasize preventive diagnostics and early disease detection, clinical chemistry remains the foundation of laboratory testing, securing its position as the largest and most frequently utilized service category.

Veterinary reference laboratory Market, By Application

Clinical pathology emerged as the largest application segment in the veterinary reference laboratory market, supported by the growing demand for comprehensive diagnostic evaluations across small and large animal practices. This segment encompasses a wide range of tests, including hematology, urinalysis, cytology, and biochemical analyses that collectively provide veterinarians with a holistic understanding of an animal’s health status. Its leadership is driven by the surge in chronic diseases, increased wellness check-ups, and the need for accurate, multi-parameter assessments to guide treatment planning. Clinical pathology serves as the backbone of diagnostic protocols, enabling early disease detection, monitoring therapy response, and improving patient outcomes. With expanding veterinary caseloads and a growing reliance on evidence-based medicine, clinical pathology remains the most critical and widely utilized application within veterinary reference laboratories.

Veterinary reference laboratory Market, By Animal type

Companion animals accounted for the largest share of the veterinary reference laboratory market, driven by rising pet ownership, increased expenditure on pet healthcare, and growing awareness of the benefits of preventive diagnostic testing. Pet owners are increasingly opting for advanced laboratory evaluations for early detection of diseases, routine wellness screening, and ongoing management of chronic conditions. Veterinary clinics and hospitals rely heavily on external reference labs for high-accuracy results and specialized testing capabilities that are not available in-house. The rise of conditions such as diabetes, renal disorders, and infectious diseases in dogs and cats further contributes to higher test volumes from companion animals. With the humanization of pets and expanding access to quality veterinary care, the companion animal segment continues to dominate the market, generating the majority of diagnostic testing demand.

Veterinary reference laboratory Market, By End User

Veterinary clinics and hospitals represent the largest end-user segment in the veterinary reference laboratory market due to their high patient volumes, frequent diagnostic requirements, and strong dependence on external laboratories for specialized and high-complexity testing. Clinics are increasingly outsourcing diagnostic services to reference labs to access advanced technologies, such as molecular diagnostics, high-throughput hematology, and specialized pathology interpretations. The growing emphasis on comprehensive diagnostic workups, preventive health panels, and rapid turnaround times reinforces the reliance on VRLs. As veterinary practices continue to expand their service offerings and adopt more data-driven clinical workflows, reference laboratories remain essential partners, supporting accurate diagnosis, treatment planning, and improved patient outcomes.

REGION

Asia Pacific to be fastest-growing region in global veterinary software market during forecast period

The Asia Pacific region is expected to grow at the highest CAGR globally in the veterinary reference laboratory market during the forecast period. This growth is primarily driven by rising pet ownership, increasing awareness of animal disease diagnostics, and the rapid expansion of veterinary healthcare services across emerging economies. Countries such as China, India, Japan, South Korea, and Australia are experiencing a surge in demand for advanced laboratory testing as the number of companion animals and veterinary professionals grows. Government programs aimed at strengthening animal health infrastructure, expanding disease surveillance networks, and improving diagnostic capacity are further accelerating market adoption. Additionally, the growing prevalence of zoonotic and infectious diseases is prompting higher utilization of PCR, serology, and pathology services across small-animal, livestock, and public health settings. The region is also witnessing an increased adoption of digital pathology, courier-enabled sample logistics, and integrated lab-reporting platforms, which enable faster turnaround times and improved clinical decision-making. With the expansion of livestock production, rising export-related testing requirements, and increasing investments from global veterinary diagnostic companies seeking to penetrate underserved markets, the Asia Pacific region is poised to become the fastest-growing and most opportunity-rich in the veterinary reference laboratory industry.

Veterinary Reference Laboratory Market Region

Veterinary Reference Laboratory Market: COMPANY EVALUATION MATRIX

In the veterinary reference laboratory market, IDEXX Laboratories, Inc. (Star) leads with unmatched diagnostic scale, extensive global laboratory infrastructure, and a comprehensive portfolio of advanced testing services. The Animal and Plant Health Agency (APHA) (Emerging Leader) is gaining momentum through its strong expertise in infectious disease surveillance, high-quality veterinary diagnostics, and robust support for national animal health programs. While IDEXX Laboratories, Inc. maintains dominance through broad market reach and deep integration with veterinary practices, APHA’s expanding diagnostic capabilities and increasing role in animal health monitoring position it for accelerated growth toward the leaders’ quadrant.

Veterinary Reference Laboratory Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

IDEXX Laboratories,Inc. (US)
Mars, Incorporated
Zoetis
GD
Laboklin
CVS (UK)
National Veterinary Services Laboratory USDA- APHIS
Animal and Plant Health Agency (APHA)
ICAR-NIVEDI
National Veterinary Services
Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL)
Animal Health Diagnostic Center, Cornell University
Colorado State University (Veterinary Diagnostic Laboratory)
Biobest Laboratories
San Marco Vet
Royal Veterinary college, University of London
University of Guelph, Animal Health Laboratory
Vaxxinova
Mira Vista Labs
Ellie Diagnostics
Protatek International, Inc.
The Pirbright Institute
CVR Laboratory
Veterinary Pathology Group
Friedrich-Loeffler-Institute (FLI)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size Value in 2024	USD 4.48 BN
Revenue Forecast in 2030	USD 6.45 BN
Growth Rate	6.3%
Actual data	2023–2030
Base year	2024
Forecast period	2025–2030
Units considered	Value (USD MN)
Report Coverage	Asia Pacific
Segments Covered	By Service: Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Histopathology & Cytology, Microbiology, Other Diagnostic Services
Regional Scope	North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: Veterinary Reference Laboratory Market REPORT CONTENT GUIDE

Veterinary Reference Laboratory Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	Comparison of key diagnostic service segments: Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Histopathology & Cytology, Microbiology, Productivity Testing, Toxicology Testing, and other specialized diagnostic services offered by veterinary reference laboratories	Identify segment-level demand shifts; Detect adoption trends toward advanced diagnostics such as PCR, sequencing, digital pathology, and high-throughput testing.
Company Information	Key players: IDEXX Laboratories (US), Zoetis Reference Laboratories (US), Mars, Incorporated (US), GD Animal Health (Netherlands), Laboklin GmbH & Co. KG (Germany)	Insights on competitive positioning; Analysis of revenue shifts driven by molecular diagnostics, AI-assisted pathology, and integrated diagnostic networks.
Geographic Analysis	Detailed regional insights on North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Country-level assessments covering disease burden, livestock population, diagnostic infrastructure, and regulatory landscape for veterinary lab services.	Country-level diagnostic demand mapping; Support for market entry strategies, new laboratory setups, and localization of specialty testing based on veterinary healthcare maturity.

RECENT DEVELOPMENTS

January 2025 : IDEXX launched the IDEXX Cancer Dx, a diagnostic panel for the early detection of lymphoma in dogs. It is a blood test that can be added to panels for sick pets and integrated into annual wellness screenings.
September 2024 : Royal GD introduced new inactivated H5N1 and H5N8 avian influenza antigens designed for the Hemagglutination Inhibition (HI) test. These updated reagents enable the precise detection of antibodies in poultry, supporting annual testing and rapid response to outbreaks.
July 2024 : LABOKLIN launched its Genetics Catalog in July 2024, featuring new and updated genetic tests and combination packages for various dog, cat, and horse breeds. Highlights include new combination panels for breeds such as Bullmastiff, Dachshund, Great Dane, and Samoyed, as well as added feline tests, including Blue Eyes, Congenital Hypothyroidism, and Polydactyly. For horses, PSSM type 1 and WFFS tests now offer fast results in 3–5 days, also included in breed-specific packages.
January 2024 : IDEXX Laboratories announced the expansion of its Fecal Dx antigen testing platform. This expansion includes Cystoisospora, a common intestinal parasite, along with hookworms, roundworms, whipworms, and flea tapeworms. The launch of Fecal Dx antigen testing with Cystoisospora is planned for March in North America and globally in Q3 2024, available at IDEXX Reference Laboratories.
January 2022 : Antech Diagnostics (part of Mars, Incorporated) announced the launch of KeyScreen GI Parasite PCR, a molecular diagnostic test that detects 20 parasites, including anthelmintic drug-resistant hookworm and zoonotic Giardia.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

RESEARCH METHODOLOGY

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Companion animal healthcare surges with digital pathology and AI, driving market expansion.

5.1

MARKET DYNAMICS

5.1.1

DRIVERS

5.1.1.1

GROWING ROUTINE WELLNESS AND ONCOLOGY SCREENING IN COMPANION ANIMALS

5.1.1.2

RAPID ADOPTION OF DIGITAL PATHOLOGY AND TELEPATHOLOGY

5.1.1.3

INCREASING PREVALENCE/AWARENESS OF ZOONOTIC AND EMERGING DISEASES

5.1.1.4

GROWTH IN COMPANION ANIMAL POPULATION

5.1.1.5

RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS

5.1.1.6

INCREASING DEMAND FOR PET INSURANCE AND GROWING ANIMAL HEALTH EXPENDITURE

5.1.2

RESTRAINTS

5.1.2.1

COMPETITION FROM IN-CLINIC AND POINT-OF-CARE TESTING

5.1.2.2

HIGH CAPITAL INVESTMENT AND FIXED COST BURDEN IN VETERINARY REFERENCE LABORATORIES

5.1.3

OPPORTUNITIES

5.1.3.1

POTENTIAL GROWTH OPPORTUNITIES IN EMERGING ECONOMIES

5.1.3.2

INVESTMENT IN ADVANCED TECHNOLOGIES IN VETERINARY REFERENCE LABORATORIES

5.1.4

CHALLENGES

5.1.4.1

COMPETITIVE PRESSURE AND MARGIN PRESSURE IN VETERINARY REFERENCE LABORATORIES

5.1.4.2

DATA PRIVACY, BIOSECURITY, AND SAMPLE OWNERSHIP IN VETERINARY REFERENCE LABORATORIES

5.2

INDUSTRY TRENDS

5.2.1

DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES

5.2.2

CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM

5.3

TECHNOLOGY ANALYSIS

5.3.1

KEY TECHNOLOGIES

5.3.1.1

REAL-TIME PCR/QUANTITATIVE PCR (QPCR) AND DIGITAL PCR (DPCR)

5.3.1.2

NEXT-GENERATION/METAGENOMIC SEQUENCING (NGS/MNGS)

5.3.1.3

CRISPR-BASED DIAGNOSTICS

5.3.2

ADJACENT TECHNOLOGIES

5.3.2.1

INTEGRATED LIMS AND ONE HEALTH SURVEILLANCE PLATFORMS

5.3.2.2

AI-DRIVEN DIAGNOSTIC TOOLS

5.3.3

COMPLEMENTARY TECHNOLOGIES

5.3.3.1

TELEPATHOLOGY

5.3.3.2

BREATH AND SALIVA-BASED DIAGNOSTIC TOOLS

5.4

PORTER’S FIVE FORCES ANALYSIS

5.4.1

THREAT OF NEW ENTRANTS

5.4.2

THREAT OF SUBSTITUTES

5.4.3

BARGAINING POWER OF SUPPLIERS

5.4.4

BARGAINING POWER OF BUYERS

5.4.5

INTENSITY OF COMPETITIVE RIVALRY

5.5

KEY STAKEHOLDERS & BUYING CRITERIA

5.5.1

KEY STAKEHOLDERS IN BUYING PROCESS

5.5.2

KEY BUYING CRITERIA

5.6

REGULATORY ANALYSIS

5.6.1

REGULATORY LANDSCAPE

5.6.1.1

NORTH AMERICA

5.6.1.2

EUROPE

5.6.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.7

PATENT ANALYSIS

5.7.1

PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY

5.7.2

JURISDICTION & TOP APPLICANT ANALYSIS

5.7.3

MAJOR PATENTS

5.8

PRICING ANALYSIS

5.8.1

AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022−2024

5.8.2

AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024

5.9

REIMBURSEMENT ANALYSIS

5.10

PET PARENT BEHAVIOUR

5.11

KEY CONFERENCES & EVENTS, 2025–2026

5.12

END-USER PERSPECTIVE & UNMET NEEDS

5.13

IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET

5.13.1

INTRODUCTION

5.13.2

MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM

5.13.3

AI-USE CASES

5.13.4

KEY COMPANIES IMPLEMENTING AI

5.14

ECOSYSTEM MAP

5.15

ROLE IN ECOSYSTEM

5.16

VALUE CHAIN ANALYSIS

5.17

INVESTMENT & FUNDING SCENARIO

5.18

CASE STUDY ANALYSIS

5.18.1

DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES

5.18.2

IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING

5.18.3

VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW

5.19

TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS

5.20

IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET

5.20.1

INTRODUCTION

5.20.2

KEY TARIFF RATES

5.20.3

PRICE IMPACT ANALYSIS

5.20.4

IMPACT ON COUNTRY/REGION

5.20.4.1

NORTH AMERICA

5.20.4.2

EUROPE

5.20.4.3

ASIA PACIFIC

5.20.4.4

LATIN AMERICA

5.20.5

IMPACT ON END-USE INDUSTRIES

5.20.5.1

VETERINARY HOSPITALS & CLINICS

5.20.5.2

POINT-OF-CARE (POC) AND IN-HOUSE TESTING SETUPS

5.20.5.3

VETERINARY RESEARCH INSTITUTES & UNIVERSITIES

5.20.5.4

OTHER END USERS

VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 51 Data Tables

141

6.1

INTRODUCTION

6.2

CLINICAL CHEMISTRY

6.2.1

VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE

6.2.1.1

COMPANION ANIMALS

6.2.1.2

LIVESTOCK ANIMALS

6.3

IMMUNODIAGNOSTICS

6.3.1

VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE

6.3.1.1

ELISA

6.3.2

LATERAL FLOW ASSAYS

6.3.2.1

TECHNOLOGICAL ADVANCEMENTS AND COST-EFFECTIVENESS TO AID MARKET GROWTH

6.3.3

ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS

6.3.3.1

RISING PREVALENCE OF ATOPIC DISORDERS AND ADOPTION OF PRECISION ALLERGY TESTING TO AUGMENT MARKET GROWTH

6.3.4

OTHER IMMUNODIAGNOSTIC SERVICES

6.3.5

VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE

6.3.5.1

COMPANION ANIMALS

6.3.5.2

LIVESTOCK ANIMALS

6.4

MOLECULAR DIAGNOSTICS

6.4.1

VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE

6.4.2

PCR TESTS

6.4.2.1

HIGH SENSITIVITY AND DIAGNOSTIC ACCURACY TO DRIVE DOMINANCE OF PCR TESTS

6.4.3

MICROARRAYS

6.4.3.1

ADVANCEMENTS IN GENETIC PROFILING AND PHARMACOGENOMICS TO EXPAND MICROARRAY APPLICATIONS

6.4.4

NUCLEIC ACID SEQUENCING

6.4.4.1

RISING ADOPTION OF NEXT-GENERATION SEQUENCING AND PRECISION GENOMICS TO FUEL MARKET GROWTH

6.4.5

OTHER MOLECULAR DIAGNOSTIC SERVICES

6.4.6

VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE

6.4.6.1

COMPANION ANIMALS

6.4.6.2

LIVESTOCK ANIMALS

6.5

HEMATOLOGY

6.5.1

VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE

6.5.1.1

COMPANION ANIMALS

6.5.1.2

LIVESTOCK ANIMALS

6.6

URINALYSIS

6.6.1

VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE

6.6.1.1

COMPANION ANIMALS

6.6.1.2

LIVESTOCK ANIMALS

6.7

HISTOPATHOLOGY & CYTOLOGY

6.7.1

VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE

6.7.1.1

COMPANION ANIMALS

6.7.1.2

LIVESTOCK ANIMALS

6.8

MICROBIOLOGY

6.8.1

VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE

6.8.1.1

COMPANION ANIMALS

6.8.1.2

LIVESTOCK ANIMALS

6.9

OTHER SERVICES

6.9.1

VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE

6.9.1.1

COMPANION ANIMALS

6.9.1.2

LIVESTOCK ANIMALS

VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables

209

7.1

INTRODUCTION

7.2

CLINICAL PATHOLOGY

7.2.1

INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET

7.3

BACTERIOLOGY

7.3.1

GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET

7.4

VIROLOGY

7.4.1

EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH

7.5

PARASITOLOGY

7.5.1

RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH

7.6

PRODUCTIVITY TESTING

7.6.1

EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH

7.7

PREGNANCY TESTING

7.7.1

ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH

7.8

TOXICOLOGY TESTING

7.8.1

GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH

7.9

OTHER APPLICATIONS

VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables

227

8.1

INTRODUCTION

8.2

COMPANION ANIMALS

8.2.1

DOGS

8.2.1.1

HIGH INSURANCE COVERAGE AND AVAILABILITY OF REIMBURSEMENTS TO DRIVE MARKET

8.2.2

CATS

8.2.2.1

INCREASING PET CAT POPULATION TO SUPPORT MARKET UPTAKE

8.2.3

HORSES

8.2.3.1

GROWING AWARENESS REGARDING EQUINE HEALTH TO FUEL MARKET GROWTH

8.2.4

OTHER COMPANION ANIMALS

8.3

LIVESTOCK ANIMALS

8.3.1

CATTLE

8.3.1.1

GROWING CONSUMPTION OF DAIRY PRODUCTS TO DRIVE MARKET GROWTH

8.3.2

SWINE

8.3.2.1

INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH

8.3.3

POULTRY

8.3.3.1

INCREASING DEMAND FOR POULTRY MEAT TO SPUR MARKET GROWTH

8.3.4

SHEEP & GOATS

8.3.4.1

INTERNATIONAL TRADE AND STRICT HEALTH REGULATIONS TO DRIVE MARKET

8.3.5

OTHER LIVESTOCK ANIMALS

VETERINARY REFERENCE LABORATORY MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables

254

9.1

INTRODUCTION

9.2

VETERINARY HOSPITALS & CLINICS

9.2.1

RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS

9.3

POINT-OF-CARE/IN-HOUSE TESTING

9.3.1

INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH

9.4

VETERINARY RESEARCH INSTITUTES & UNIVERSITIES

9.4.1

INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES

9.5

OTHER END USERS

VETERINARY REFERENCE LABORATORY MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 19 Countries | 526 Data Tables.

264

10.1

INTRODUCTION

10.2

NORTH AMERICA

10.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

10.2.2

10.2.2.1

US TO DOMINATE NORTHS AMERICAN VETERINARY REFERENCE LABORATORY MARKET DURING FORECAST PERIOD

10.2.3

CANADA

10.2.3.1

GROWING PET ADOPTION, RISING ANIMAL HEALTHCARE EXPENDITURE, AND INCREASING NUMBER OF VETERINARY PRACTICES TO DRIVE MARKET

10.3

EUROPE

10.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

10.3.2

GERMANY

10.3.2.1

INCREASING PET HEALTHCARE EXPENDITURE AND RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO AID MARKET GROWTH

10.3.3

10.3.3.1

INCREASED PET OWNERSHIP AND AVAILABILITY OF ANIMAL HEALTH INSURANCE POLICIES TO AUGMENT MARKET GROWTH

10.3.4

FRANCE

10.3.4.1

GROWTH OF LIVESTOCK INDUSTRY AND HIGH COMPANION ANIMAL POPULATION TO SUPPORT MARKET GROWTH

10.3.5

ITALY

10.3.5.1

RISING AWARENESS ABOUT PET HEALTHCARE TO DRIVE MARKET

10.3.6

SPAIN

10.3.6.1

GROWING DEMAND FOR PIG AND POULTRY PRODUCTS TO DRIVE MARKET

10.3.7

NETHERLANDS

10.3.7.1

INCREASING ANIMAL HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH

10.3.8

REST OF EUROPE

10.4

ASIA PACIFIC

10.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

10.4.2

CHINA

10.4.2.1

LARGE POOL OF FOOD-PRODUCING ANIMALS TO DRIVE MARKET

10.4.3

JAPAN

10.4.3.1

AWARENESS ABOUT ZOONOTIC DISEASES AND INCREASED PET EXPENDITURE TO PROPEL MARKET GROWTH

10.4.4

INDIA

10.4.4.1

GROWING DEMAND FOR LIVESTOCK PRODUCTS AND INCREASING AWARENESS ABOUT ANIMAL HEALTH TO SUPPORT MARKET GROWTH

10.4.5

AUSTRALIA

10.4.5.1

INCREASING INVESTMENTS IN PET SERVICES AND PRODUCTS TO AID MARKET GROWTH

10.4.6

SOUTH KOREA

10.4.6.1

INCREASING PET POPULATION IN URBAN HOUSEHOLDS TO DRIVE MARKET

10.4.7

THAILAND

10.4.7.1

RAPIDLY EXPANDING COMPANION ANIMAL POPULATION TO CREATE HIGHER DEMAND FOR ADVANCED DIAGNOSTIC TESTING

10.4.8

NEW ZEALAND

10.4.8.1

INCREASED DEMAND FOR PREVENTIVE CARE AND HIGH AGING PET POPULATION TO DRIVE MARKET GROWTH

10.4.9

REST OF ASIA PACIFIC

10.5

LATIN AMERICA

10.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

10.5.2

BRAZIL

10.5.2.1

INCREASING USE OF REPRODUCTIVE TECHNOLOGIES IN LIVESTOCK INDUSTRY TO PROPEL MARKET GROWTH

10.5.3

MEXICO

10.5.3.1

INCREASING ADOPTION OF ADVANCED DIAGNOSTIC TECHNOLOGIES TO PROPEL MARKET GROWTH

10.5.4

ARGENTINA

10.5.4.1

FOCUS ON ADVANCED HEALTHCARE AND REGULAR DISEASE MONITORING AMONG COMPANION ANIMALS TO DRIVE MARKET

10.5.5

REST OF LATIN AMERICA

10.6

MIDDLE EAST & AFRICA

10.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10.6.2

GCC COUNTRIES

10.6.2.1

KINGDOM OF SAUDI ARABIA

10.6.2.2

UAE

10.6.2.3

REST OF GCC COUNTRIES

10.6.3

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Discover strategic maneuvers and market positions shaping the veterinary reference laboratory industry.

490

11.1

INTRODUCTION

11.2

KEY PLAYER STRATEGIES/RIGHT TO WIN

11.2.1

OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET

11.3

REVENUE ANALYSIS, 2020−2024

11.4

MARKET SHARE ANALYSIS, 2024

11.4.1

RANKING OF KEY MARKET PLAYERS

11.4.2

GLOBAL MARKET SHARE ANALYSIS

11.4.3

US MARKET SHARE ANALYSIS

11.5

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024

11.5.1

STARS

11.5.2

EMERGING LEADERS

11.5.3

PERVASIVE PLAYERS

11.5.4

PARTICIPANTS

11.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2024

11.5.5.1

COMPANY FOOTPRINT

11.5.5.2

REGION FOOTPRINT

11.5.5.3

SERVICE FOOTPRINT

11.5.5.4

ANIMAL TYPE FOOTPRINT

11.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024

11.6.1

PROGRESSIVE COMPANIES

11.6.2

RESPONSIVE COMPANIES

11.6.3

DYNAMIC COMPANIES

11.6.4

STARTING BLOCKS

11.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024

11.6.5.1

DETAILED LIST OF KEY STARTUPS/SME PLAYERS

11.6.5.2

COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS

11.7

BRAND/PRODUCT COMPARISON

11.8

R&D EXPENDITURE OF KEY PLAYERS

11.9

COMPANY VALUATION & FINANCIAL METRICS

11.9.1

FINANCIAL METRICS

11.9.2

COMPANY VALUATION

11.10

COMPETITIVE SCENARIO

11.10.1

SERVICE LAUNCHES & ENHANCEMENTS

11.10.2

DEALS

11.10.3

EXPANSIONS

11.10.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

515

12.1

KEY PLAYERS

12.1.1

IDEXX LABORATORIES, INC.

12.1.1.1

BUSINESS OVERVIEW

12.1.1.2

SERVICES OFFERED

12.1.1.3

RECENT DEVELOPMENTS

12.1.1.4

MNM VIEW

12.1.2

MARS, INCORPORATED

12.1.3

ZOETIS SERVICES LLC

12.1.4

GD (ROYAL GD ANIMAL HEALTH)

12.1.5

LABOKLIN GMBH & CO. KG

12.1.6

CVS (UK) LIMITED

12.1.7

NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS

12.1.8

ANIMAL AND PLANT HEALTH AGENCY

12.1.9

ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)

12.1.10

NATIONAL VETERINARY SERVICES

12.1.11

TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)

12.1.12

ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY

12.1.13

COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)

12.1.14

BIOBEST LABORATORIES LTD.

12.1.15

PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE

12.2

OTHER PLAYERS

12.2.1

ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON

12.2.2

UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY

12.2.3

VAXXINOVA

12.2.4

MIRA VISTA LABS

12.2.5

ELLIE DIAGNOSTICS

12.2.6

PROTATEK INTERNATIONAL, INC.

12.2.7

THE PIRBRIGHT INSTITUTE

12.2.8

CVR LABORATORY (CVRL)

12.2.9

VETERINARY PATHOLOGY GROUP

12.2.10

FRIEDRICH-LOEFFLER-INSTITUT (FLI)

APPENDIX

595

13.1

DISCUSSION GUIDE

13.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

13.3

CUSTOMIZATION OPTIONS

13.3.1

SERVICE ANALYSIS

13.3.2

Methodology

This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study utilized comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to an in-depth, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary reference laboratory. Primary sources from the demand side include healthcare professionals from veterinary hospitals, veterinary clinics, and veterinary diagnostic centers.

A breakdown of the primary respondents is provided below:

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary reference laboratory was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Veterinary reference laboratories refer to specialized diagnostic facilities that perform routine and advanced testing services for the detection, confirmation, and monitoring of animal diseases and disorders. These laboratories utilize a wide range of diagnostic methodologies, including clinical chemistry, hematology, immunodiagnostics, molecular diagnostics, urinalysis, microbiology, histopathology, toxicology, productivity testing, and pregnancy testing, to support evidence-based veterinary care. The market covers laboratory-based diagnostic services provided for companion and livestock animals by veterinary clinics and hospitals, research institutes, universities, point-of-care/in-house labs, government and public health agencies, and other end users. This report studies the market for such diagnostic services offered by reference laboratories while excluding laboratory software, imaging systems, and biopsy/necropsy services.

Stakeholders

Veterinary Diagnostic Manufacturers
Veterinary Diagnostic Distributors
Animal Health R&D Companies
Government Associations
Veterinary reference laboratories
Veterinary Healthcare Institutions (Hospitals & Outpatient Clinics)
Research Institutes
Health Insurance Payers
Venture capitalists
Market Research and Consulting Firms
World Organisation for Animal Health
Organization for Economic Co-operation and Development (OECD)

Report Objectives

To define, describe, and forecast the veterinary reference laboratory based on service, application, animal type, end user, and region
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges).
To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total veterinary reference laboratory
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
To profile the key market players and comprehensively analyze their market shares and core competencies.
To forecast the revenue of the market segments with respect to five main regions, namely, North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, New Zealand, Australia, Thailand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa {GCC Countries [Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), and Rest of GCC Countries] and Rest of MEA}.
To track and analyze competitive developments such as service launches, agreements, partnerships, expansions, acquisitions, and collaborations in the veterinary reference laboratory

Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030

OVERVIEW

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Growing routine wellness & oncology screening in companion animals

Restraint: Competition from in-clinic & point-of-care testing

Opportunity: Growth potential in emerging economies

Challenge: Data privacy, biosecurity, and sample ownership in veterinary reference laboratories

Veterinary Reference Laboratory Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Veterinary reference laboratory Market, By Service

Veterinary reference laboratory Market, By Application

Veterinary reference laboratory Market, By Animal type

Veterinary reference laboratory Market, By End User

REGION

Asia Pacific to be fastest-growing region in global veterinary software market during forecast period

Veterinary Reference Laboratory Market: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: Veterinary Reference Laboratory Market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Stakeholders

Report Objectives

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Personalize This Research

Let Us Help You

Growth opportunities and latent adjacency in Veterinary Reference Laboratory Market